Septic shock in patients admitted to intensive care unit with COVID-19 pneumonia

IF 0.1 Q4 RESPIRATORY SYSTEM Eurasian Journal of Pulmonology Pub Date : 2021-05-01 DOI:10.4103/ejop.ejop_101_20
Kazım Rollas, G. Ersan, Ç. Zincircioğlu, I. Sahar, Taner Çalışkan, I. Güldoğan, Aykut Sarıtaş, Uğur Uzun, N. Şenoğlu
{"title":"Septic shock in patients admitted to intensive care unit with COVID-19 pneumonia","authors":"Kazım Rollas, G. Ersan, Ç. Zincircioğlu, I. Sahar, Taner Çalışkan, I. Güldoğan, Aykut Sarıtaş, Uğur Uzun, N. Şenoğlu","doi":"10.4103/ejop.ejop_101_20","DOIUrl":null,"url":null,"abstract":"BACKGROUND: The aim of this study was to determine mortality rates and to evaluate clinical features of coronavirus disease 2019 (COVID-19) patients with septic shock in intensive care unit (ICU). MATERIALS AND METHODS: The medical records of COVID-19 patients requiring ICU admission were retrospectively reviewed over a 3-month period. RESULTS: Forty patients with COVID-19 admitted to the ICU were screened. Two patients died within 24 h after ICU admission. After these patients were excluded, septic shock was detected in 11 (28%) of 38 patients during the 30-day follow-up period. Ten (91%) of the 11 patients with septic shock died in the ICU. Eight (72%) of the 11 patients had nosocomial infection during 30-day follow-up period. Six (54%) of 11 septic shock patients had positive culture results for bacterial pneumonia on the day of septic shock. The median time from symptom onset to septic shock was 14 (5–34) days. The median duration from ICU admission until septic shock was 8 (1–28) days. All of the patients with septic shock underwent invasive mechanical ventilation (IMV). CONCLUSION: COVID-19 patients with septic shock have higher mortality rates, percentage of nosocomial infection, and IMV requirement.","PeriodicalId":42933,"journal":{"name":"Eurasian Journal of Pulmonology","volume":"23 1","pages":"95 - 100"},"PeriodicalIF":0.1000,"publicationDate":"2021-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Eurasian Journal of Pulmonology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/ejop.ejop_101_20","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 2

Abstract

BACKGROUND: The aim of this study was to determine mortality rates and to evaluate clinical features of coronavirus disease 2019 (COVID-19) patients with septic shock in intensive care unit (ICU). MATERIALS AND METHODS: The medical records of COVID-19 patients requiring ICU admission were retrospectively reviewed over a 3-month period. RESULTS: Forty patients with COVID-19 admitted to the ICU were screened. Two patients died within 24 h after ICU admission. After these patients were excluded, septic shock was detected in 11 (28%) of 38 patients during the 30-day follow-up period. Ten (91%) of the 11 patients with septic shock died in the ICU. Eight (72%) of the 11 patients had nosocomial infection during 30-day follow-up period. Six (54%) of 11 septic shock patients had positive culture results for bacterial pneumonia on the day of septic shock. The median time from symptom onset to septic shock was 14 (5–34) days. The median duration from ICU admission until septic shock was 8 (1–28) days. All of the patients with septic shock underwent invasive mechanical ventilation (IMV). CONCLUSION: COVID-19 patients with septic shock have higher mortality rates, percentage of nosocomial infection, and IMV requirement.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
重症监护病房收治的COVID-19肺炎患者的感染性休克
背景:本研究旨在确定2019冠状病毒病(COVID-19)重症监护病房(ICU)脓毒性休克患者的死亡率并评估其临床特征。材料与方法:回顾性分析3个月入院的COVID-19 ICU患者的病历。结果:共筛选出40例新冠肺炎住院ICU患者。2例患者入院后24 h内死亡。排除这些患者后,在30天的随访期间,38例患者中有11例(28%)检测到感染性休克。11例脓毒性休克患者中有10例(91%)在ICU死亡。随访30天,11例患者中有8例(72%)发生院内感染。11例脓毒性休克患者中6例(54%)在脓毒性休克当日细菌性肺炎培养结果阳性。从症状出现到感染性休克的中位时间为14(5-34)天。从ICU入院到感染性休克的中位持续时间为8(1-28)天。所有脓毒性休克患者均行有创机械通气(IMV)。结论:新型冠状病毒肺炎合并感染性休克患者的死亡率、医院感染比例和IMV需求均较高。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Eurasian Journal of Pulmonology
Eurasian Journal of Pulmonology RESPIRATORY SYSTEM-
自引率
0.00%
发文量
9
审稿时长
16 weeks
期刊最新文献
The relationship between thyroid transcription factor-1 positivity and epidermal growth factor receptor mutation in lung adenocarcinoma and its prognostic significance IL-6 level but not MBL level is associated with disease severity in hospitalized patients with COVID-19 Effects of one-leg exercises in rehabilitation of chronic obstructive pulmonary disease: A systematic review Pulmonary embolism as the first sign of hepatocellular carcinoma in a patient who was cured after five years Acute Interstitial Pneumonia Associated with Vinorelbine Usage
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1